13G Filing: Scopia Capital Raises Stake in Insys Therapeutics, Inc. (INSY)

Page 10 of 12

Page 10 of 12 SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
March 10, 2016
(Date)
SCOPIA CAPITAL MANAGEMENT LP
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  COO
SCOPIA MANAGEMENT, INC.
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  Vice President
By: /s/ Matthew Sirovich
Name:  Matthew Sirovich
By: /s/ Jeremy Mindich
Name:  Jeremy Mindich
Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are to be sent.
Attention.  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Insys Therapeutics Inc. (NASDAQ:INSY)

Page 10 of 12